These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 37587888)
21. Protective effects of melatonin on mitochondrial biogenesis and mitochondrial structure and function in the HEK293-APPswe cell model of Alzheimer's disease. Wang CF; Song CY; Wang X; Huang LY; Ding M; Yang H; Wang P; Xu LL; Xie ZH; Bi JZ Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3542-3550. PubMed ID: 31081111 [TBL] [Abstract][Full Text] [Related]
22. A map of the PPARα transcription regulatory network for primary human hepatocytes. McMullen PD; Bhattacharya S; Woods CG; Sun B; Yarborough K; Ross SM; Miller ME; McBride MT; LeCluyse EL; Clewell RA; Andersen ME Chem Biol Interact; 2014 Feb; 209():14-24. PubMed ID: 24269660 [TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels. Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106 [TBL] [Abstract][Full Text] [Related]
24. Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer's disease. Reddy PH; Manczak M; Kandimalla R Hum Mol Genet; 2017 Apr; 26(8):1483-1496. PubMed ID: 28186562 [TBL] [Abstract][Full Text] [Related]
25. Selective serotonin reuptake inhibitor citalopram ameliorates cognitive decline and protects against amyloid beta-induced mitochondrial dynamics, biogenesis, autophagy, mitophagy and synaptic toxicities in a mouse model of Alzheimer's disease. Reddy AP; Sawant N; Morton H; Kshirsagar S; Bunquin LE; Yin X; Reddy PH Hum Mol Genet; 2021 May; 30(9):789-810. PubMed ID: 33791799 [TBL] [Abstract][Full Text] [Related]
26. Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer's disease. Reddy AP; Yin X; Sawant N; Reddy PH Hum Mol Genet; 2021 May; 30(10):847-864. PubMed ID: 33615359 [TBL] [Abstract][Full Text] [Related]
27. Cinnamic acid activates PPARα to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer's disease mouse model. Chandra S; Roy A; Jana M; Pahan K Neurobiol Dis; 2019 Apr; 124():379-395. PubMed ID: 30578827 [TBL] [Abstract][Full Text] [Related]
28. Impairment of PGC-1α-mediated mitochondrial biogenesis precedes mitochondrial dysfunction and Alzheimer's pathology in the 3xTg mouse model of Alzheimer's disease. Singulani MP; Pereira CPM; Ferreira AFF; Garcia PC; Ferrari GD; Alberici LC; Britto LR Exp Gerontol; 2020 May; 133():110882. PubMed ID: 32084533 [TBL] [Abstract][Full Text] [Related]
29. Protective effects of a small molecule inhibitor, DDQ against amyloid beta in Alzheimer's disease. Vijayan M; Bose C; Reddy PH Mitochondrion; 2021 Jul; 59():17-29. PubMed ID: 33839321 [TBL] [Abstract][Full Text] [Related]
30. MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease. Pohland M; Pellowska M; Asseburg H; Hagl S; Reutzel M; Joppe A; Berressem D; Eckert SH; Wurglics M; Schubert-Zsilavecz M; Eckert GP Alzheimers Res Ther; 2018 Feb; 10(1):18. PubMed ID: 29433569 [TBL] [Abstract][Full Text] [Related]
32. Fenofibrate reduces amyloidogenic processing of APP in APP/PS1 transgenic mice via PPAR-α/PI3-K pathway. Zhang H; Gao Y; Qiao PF; Zhao FL; Yan Y Int J Dev Neurosci; 2014 Nov; 38():223-31. PubMed ID: 25447788 [TBL] [Abstract][Full Text] [Related]
33. Treadmill workout activates PPARα in the hippocampus to upregulate ADAM10, decrease plaques and improve cognitive functions in 5XFAD mouse model of Alzheimer's disease. Rangasamy SB; Jana M; Dasarathi S; Kundu M; Pahan K Brain Behav Immun; 2023 Mar; 109():204-218. PubMed ID: 36682514 [TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptor-α activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway. Nakaya K; Tohyama J; Naik SU; Tanigawa H; MacPhee C; Billheimer JT; Rader DJ Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1276-82. PubMed ID: 21441141 [TBL] [Abstract][Full Text] [Related]
35. Activation of Liver X Receptors and Peroxisome Proliferator-Activated Receptors by Lipid Extracts of Brown Seaweeds: A Potential Application in Alzheimer's Disease? Martens N; Zhan N; Voortman G; Leijten FPJ; van Rheenen C; van Leerdam S; Geng X; Huybrechts M; Liu H; Jonker JW; Kuipers F; Lütjohann D; Vanmierlo T; Mulder MT Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447330 [TBL] [Abstract][Full Text] [Related]
36. Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway. Duncan JG; Fong JL; Medeiros DM; Finck BN; Kelly DP Circulation; 2007 Feb; 115(7):909-17. PubMed ID: 17261654 [TBL] [Abstract][Full Text] [Related]
37. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver. Kersten S; Stienstra R Biochimie; 2017 May; 136():75-84. PubMed ID: 28077274 [TBL] [Abstract][Full Text] [Related]